Artificial neural network model for predicting HIV protease cleavage sites in protein

Advances in Engineering Software

Volumn 29, Issue 2, 1998, Pages 119-128

  Cai, Yu Dong ^a,c   Chou, Kuo Chen ^b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b Kalamazoo ^*  (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Artificial neural network; Back propagation model; Cleavage sites; HIV protease

Indexed keywords

BACKPROPAGATION; DISEASES; ENZYME INHIBITION; FAULT TOLERANT COMPUTER SYSTEMS; MATHEMATICAL MODELS; PROTEINS; VIRUSES;

HIV PROTEASE; OLIGOPEPTIDES; POLYPROTEIN CLEAVAGE;

NEURAL NETWORKS;

EID: 0032017815     PISSN: 09659978     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0965-9978(98)00046-5     Document Type: Article

References (28)

1. 1. Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W. and Montagnier, L., Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 1983, 220, 868-871.
2. 2. Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P. and Markham, P. D., Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science, 1984, 224, 500-503.
3. 3. Kohl, N. E., Emini, E. A., Schlief, W. A., Davis, L. J., Heimbach, J., Dixon, R. A.F., Scolnik, E. M. and Sigal, I. S., Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Sci. USA, 1988, 85, 4686-4690.
4. 4. Seelmeier, S., Schmidt, H., Turk, V. and van der Helm, K., Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proc. Natl. Acad. Sci. USA, 1988, 85, 6612-6616.
5. 5. Hellen, C. U. T., Kräusslich, H. G. and Wimmer, E., Proteolytic processing of polyproteins in the replication of RNA viruses. Biochemistry, 1989, 28, 9881-9890.
6. 6. McQuade, T. J., Tornasselli, A. G., Liu, L., Karacostas, V., Moss, B., Sawyer, T. K., Heinrikson, H. L. and Tarpley, W. J., An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Science, 1990, 247, 454-456.
7. 7. Graves, B. J., Hatada, M. H., Miller, J. K., Graves, M. C., Roy, S., Cook, C. M., Króhn, A., Martin, J. A. and Roberts, N. A., The three-dimensional x-ray crystal structure of HIV-1 protease complexed with a hydroxyethylene inhibitor. In Structure ana Function of the Aspartic Protease: Genetics, Structure and Mechanisms, ed. B. Dunn, Plenum, New York, 1992, pp. 455-460.
8. 8. Mitsuya, H., Yarchomi, R. and Broder, S., Molecular targets for AIDS therapy. Science, 1990, 249, 1533-1544.
9. 9. Meek, T. D., Lambert, D. M., Dreyer, G. B., Carr, J. T., Tomaszek Jr, T. A., Moore, M. L., Strickler, J. E., Debouck, C., Hyland, L. J., Matthews, J. T., Metcalf, B. W. and Petteway, S. R., Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature, 1990, 343, 90-92.
10. 10. Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Krohn, A., Lambert, R. W., Merrett, J. H., Mills, J. S., Parkes, K. E. B., Redshaw, S., Ritchie, A. J., Taylor, D. L., Thomas, G. J. and Machin, P. J., Rational design of peptide-based HIV proteinase inhibitors. Science, 1990, 248, 358-361.
11. 11. Ashorn, P., McQuade, T. J., Thaisrivongs, S., Tomasselli, A. G., Tarpley, W. J. and Moss, B., An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proc. Natl. Acad. Sci. USA., 1990, 87, 7472-7476.
12. 12. Wlodawer, A. and Erickson, J. W., Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem., 1993, 62, 543-585.
13. 13. Tomasselli, A. G., Hui, J. O., Sawyer, T. K., Thaisrivongs, S., Hester, J. B. and Heinrikson, R. L., The evaluation of non-viral substrates of the HIV protease as leads in the design of inhibitors for AIDS therapy. In Structure and Function of Aspartic Proteases, ed. B. M. Dunn. Plenum Press, New York, 1991, pp. 469-482.
14. 14. Henderson, L. E., Benveniste, R. E., Sowder, R. C., Copeland, T. D., Schutz, A. M. and Oroszlan, S., Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J. Virol., 1988, 62, 2587-2595.
15. 15. Putney, S., How antibodies block HIV infection: paths to an AIDS vaccine. TIBS, 1992, 17, 191-196.
16. 16. Toh, H., One, M., Saigo, K. and Miyata, T., Retroviral gag and DNA endonuclease coding sequences in IgE-binding factor gene. Nature, 1985, 315, 691-691.
17. 17. Pearl, L. and Talyor, W., A structural model for the retroviral proteases. Nature, 1987, 329, 351-354.
18. 18. Lapatto, R., Blundell, T., Hemmings, A., Overington, J., Wilderspin, A., Wood, S., Merson, J. R., White, P. J., Danley, D. E., Geoghegan, K. F., Hawrylik, S. J., Lee, S. W., Scheld, K. G. and Hobart, P. M., X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes. Nature, 1989, 342, 299-302.
19. 19. Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, G. R., Clawson, L., Selk, L., Kent, S. B. H. and Wlodawer, A., Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution. Science, 1989, 246, 1149-1152.
20. 20. Chou, K. C., A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J. Biol. Chem., 1993, 268, 16938-16948.
21. 21. Poorman, R. A., Tomasselli, A. G., Heinrikson, R. L. and Kézdy, F. J., A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J. Biol. Chem., 1991, 266, 14554-14561.
22. 22. Chou, K. C., Zhang, C. T. and Kézdy, F. J., A vector projection approach to predicting HIV protease cleavage sites in proteins. PROTEINS: Structure, Function and Genetics, 1993, 16, 195-204.
23. 23. Chou, J. J., Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach. J. Protein Chem., 1993, 12, 291-302.
24. 24. Chou, K. C. and Zhang, C. T., Studies on the specificity of HIV protease: an application of Markov chain theory. J. Protein Chem., 1993, 12, 709-724.
25. 25. Zhang, C. T. and Chou, K. C., An alternate-subsite-coupled model for predicting HIV protease sites in proteins. Protein Engineering. 1994, 7, 65-73.
26. 26. Chou, K. C., Tomasselli, A. G., Reardon, I. M. and Heinrikson, R. L., Predicting HIV protease cleavage sites in proteins by a discriminant function method. PROTEINS: Structure, Function and Genetics, 1996, 24, 51-72.
27. 27. Chou, K-C., Prediction of human immunodeficiency virus protease cleavage sites in proteins. Analytical Biochemistry, 1996, 233, 1-14.
28. 28. Werbos, P. J., Beyond regression: New tools for prediction and analysis in behavioral sciences. Ph.D. dissertation, Appl. Math., Harvard University, Cambridge, MA, USA, 1974.